Guo's Visceral Arteries Reconstruction: First in Man Study

Exclusion Criteria

• •1. Ruptured aortic aneurysm in unstable haemodynamic condition;
• •2. Aneurysmal aortic dissection;
• •3. Infected or mycotic aortic aneurysm;
• •4. Requiring simultaneous coverage or embolisation for bilateral internal iliac arteries;
• •5. Severe stenosis, calcification, or mural thrombus at stent-graft landing zone;
• •6. Diagnosis of acute coronary syndrome within 6 months;
• •7. Patients with any transient ischemic attack (TIA) or ischemic stroke within 3 months;
• •8. An allergic history for contrast agents, anticoagulants, antiplatelet drugs, stent graft or materials of delivery system；
• •9. Patients with connective tissue diseases;
• •10. Patients with takayasu arteritis;
• •11. Patients with serious vital organ dysfunction or other serious disease;
• •12. Preoperative liver renal function abnormalities (ALT or AST ≥ 5 times the upper limit of normal value), or serum creatinine ≥ 150 μmol/L;
• •13. Severe pulmonary insufficiency who cannot tolerate general anaesthesia;
• •14. Severe coagulation dysfunction;
• •15. Undergone major surgical or interventionic surgery within 30 days before surgery;
• •16. Patients whose systemic or local infection may increase the risk of intravascular graft infection;
• •17. Planning pregnancy, pregnancy, or breastfeeding;
• •18. The patient participated in other clinical trials or not completed or withdrawn from other clinical trials within the last 3 months at the time of screening period ;
• •19. Life expectancy less than 1 year;
• •20. Patients not appropriate for endovascular repair based on the investigators' clinical judgement.